Stockreport

GRI Bio Announces Closing of $4.0 Million Public Offering [Yahoo! Finance]

GRI Bio, Inc.  (GRI) 
PDF innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced the closing of its p [Read more]